In breast cancer, tumor stromal cells such as cancer‐associated fibroblasts (CAFs) mainly contribute to abnormal ECM deposition in response to several paracrine factors such as reactive oxygen species (ROS), transforming growth factor‐beta (TGF‐β), and platelet‐derived growth factor (PDGF).9 This evidence concerns the gene TGFB1 and breast cancer.